IMP3 protein is an independent prognostic factor of clinical stage II rectal cancer
Abstract Immunohistochemical level of IMP3-protein in patients with rectal cancer in clinical stage II (141), were correlated with sociodemographic, pathohistological and clinical indicators and duration of overall-survival and progression-free-survival. Vascular invasion was associated with IMP3-po...
Guardado en:
Autores principales: | Daniela Bevanda Glibo, Danijel Bevanda, Katarina Vukojević, Snježana Tomić |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/175a816d1b22478ebc2aac18b0b9fc5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
P21 is not a prognostic marker for rectal cancer – five-year follow up study of rectal cancer in stages I–IV
por: Monika A. Kozłowska-Geller, et al.
Publicado: (2021) -
The structural basis for RNA selectivity by the IMP family of RNA-binding proteins
por: Jeetayu Biswas, et al.
Publicado: (2019) -
Combinatorial recognition of clustered RNA elements by the multidomain RNA-binding protein IMP3
por: Tim Schneider, et al.
Publicado: (2019) -
Structure and catalytic regulation of Plasmodium falciparum IMP specific nucleotidase
por: Loïc Carrique, et al.
Publicado: (2020) -
Do Certain Flavonoid IMPS Have a Vital Function?
por: David S. Seigler, et al.
Publicado: (2021)